Salarius Pharmaceuticals, Inc. - Common Stock (SLRX)
0.7265
+0.00 (0.00%)
NASDAQ · Last Trade: Apr 3rd, 4:25 AM EDT
Via Benzinga · March 27, 2025
Via Benzinga · March 26, 2025

Deal opportunities abound: KKR & Co.'s stake in Maya; DuPont's electronics business; Ingevity's North Charleston site; and S&W Seed Company.
Via Benzinga · January 17, 2025

Via Benzinga · July 30, 2024

Via Benzinga · January 14, 2025

Salarius Pharmaceuticals (NASDAQ: SLRX) shares are trading higher Monday after the company announced a merger agreement with Decoy Therapeutics, a privately held biopharmaceutical company.
Via Benzinga · January 13, 2025

Via Benzinga · January 13, 2025

SLRX stock results show that Salarius Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 12, 2024

Via Benzinga · July 25, 2024

It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news to start the day with!
Via InvestorPlace · July 24, 2024

While Salarius Pharmaceuticals encountered a hiccup in its genomics research, the possibility of new funding may have lifted SLRX stock.
Via InvestorPlace · July 23, 2024

Via Benzinga · July 22, 2024

Via Benzinga · July 23, 2024

Via Benzinga · July 22, 2024

Via Benzinga · July 19, 2024

Pre-market stock movers are a hot topic on Friday as we check out all of the stories affecting shares on the last day of trading this week!
Via InvestorPlace · July 19, 2024

Via Benzinga · July 19, 2024

Pre-market stock movers are a hot topic on Thursday and we have breakdowns of all the latest news affecting shares this morning!
Via InvestorPlace · July 11, 2024

Via Benzinga · July 4, 2024

Via Benzinga · June 20, 2024

Via Benzinga · June 10, 2024